Awakn Life Sciences Reports Second Quarter 2021 Financial Results and Business Highlights Psychedelics Investing
COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs Psychedelics Investing
NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference Psychedelics Investing
COMPASS Pathways to participate in Citi, Morgan Stanley and HC Wainwright investor conferences in September Psychedelics Investing
Seelos Therapeutics Announces Appointment of Margaret Dalesandro to the Board of Directors Psychedelics Investing
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
